Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |